Du F, Li J, Zhong X, Zhang Z, Zhao Y
Heliyon. 2024; 10(21):e40118.
PMID: 39568849
PMC: 11577214.
DOI: 10.1016/j.heliyon.2024.e40118.
Huang Y, Wang J, Xu J, Ruan N
Oncol Res. 2024; 32(11):1765-1776.
PMID: 39449815
PMC: 11497182.
DOI: 10.32604/or.2024.045564.
Yi Q, Zhu G, Zhu W, Wang J, Ouyang X, Yang K
Oncol Rep. 2024; 52(6).
PMID: 39392043
PMC: 11487528.
DOI: 10.3892/or.2024.8821.
Qin H, Lu H, Qin C, Huang X, Peng K, Li Y
J Cancer. 2024; 15(17):5515-5539.
PMID: 39308669
PMC: 11414603.
DOI: 10.7150/jca.98449.
Wang S, Wang S, Pan W, Yi Y, Lu J
PLoS Comput Biol. 2024; 20(9):e1012444.
PMID: 39255326
PMC: 11414978.
DOI: 10.1371/journal.pcbi.1012444.
Platelet-Derived Growth Factor C Facilitates Malignant Behavior of Pancreatic Ductal Adenocarcinoma by Regulating SREBP1 Mediated Lipid Metabolism.
Shi Y, Liu Z, Ma M, Zhao G, Zhu Y, Wang J
Adv Sci (Weinh). 2024; 11(40):e2407069.
PMID: 39225567
PMC: 11516052.
DOI: 10.1002/advs.202407069.
De novo Antineoplastic Drug Design to Suppress Head, Neck and Oral Cancer using Theoretical Organic and Biochemistry via Comprehensive Molecular Docking and Dynamics.
Agar S, Mokhtari M, Yanik M, Akkurt B, Ulukaya E, Terzi R
Asian Pac J Cancer Prev. 2024; 25(8):2905-2909.
PMID: 39205589
PMC: 11495462.
DOI: 10.31557/APJCP.2024.25.8.2905.
Assessing TGF-β Prognostic Model Predictions for Chemotherapy Response and Oncogenic Role of FKBP1A in Liver Cancer.
Chen W, Que Q, Zhong R, Lin Z, Yi Q, Wang Q
Curr Pharm Des. 2024; 30(39):3131-3152.
PMID: 39185649
DOI: 10.2174/0113816128326151240820105525.
N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance.
Ma M, Shi Y, Liu Z, Zhu Y, Zhao G, Ye J
Oncogene. 2024; 43(31):2405-2420.
PMID: 38914663
PMC: 11281907.
DOI: 10.1038/s41388-024-03092-3.
Machine learning identifies the role of SMAD6 in the prognosis and drug susceptibility in bladder cancer.
Chen Z, Ou Y, Ye F, Li W, Jiang H, Liu S
J Cancer Res Clin Oncol. 2024; 150(5):264.
PMID: 38767747
PMC: 11106122.
DOI: 10.1007/s00432-024-05798-z.
Research status and prospects of pituitary adenomas in conjunction with neurological and psychiatric disorders and the tumor microenvironment.
Cui S, Chen S, Wu X, Wang Q
Front Neurosci. 2024; 18:1294417.
PMID: 38716256
PMC: 11075501.
DOI: 10.3389/fnins.2024.1294417.
The FTO Mediated N6-Methyladenosine Modification of DDIT4 Regulation with Tumorigenesis and Metastasis in Prostate Cancer.
Zhao Y, Hu X, Yu H, Sun H, Zhang L, Shao C
Research (Wash D C). 2024; 7:0313.
PMID: 38384328
PMC: 10879844.
DOI: 10.34133/research.0313.
Genetically predicted circulating levels of cytokines and the risk of oral cavity and pharyngeal cancer: a bidirectional mendelian-randomization study.
Wu K, Sun Q, Liu D, Lu J, Wen D, Zang X
Front Genet. 2024; 14:1321484.
PMID: 38274108
PMC: 10808506.
DOI: 10.3389/fgene.2023.1321484.
Transforming Growth Factor-β/Smad Signaling Inhibits Melanoma Cancer Stem Cell Self-Renewal, Tumor Formation and Metastasis.
Boudreault J, Wang N, Ghozlan M, Lebrun J
Cancers (Basel). 2024; 16(1).
PMID: 38201651
PMC: 10778361.
DOI: 10.3390/cancers16010224.
Epitranscriptional regulation of TGF-β pseudoreceptor BAMBI by m6A/YTHDF2 drives extrinsic radioresistance.
Wang L, Si W, Yu X, Piffko A, Dou X, Ding X
J Clin Invest. 2023; 133(24).
PMID: 38099498
PMC: 10721150.
DOI: 10.1172/JCI172919.
TGF-β in correlation with tumor progression, immunosuppression and targeted therapy in colorectal cancer.
Singh S, Gouri V, Samant M
Med Oncol. 2023; 40(11):335.
PMID: 37855975
DOI: 10.1007/s12032-023-02204-5.
Identification of immune-related signature with prognosis in children with stage 4 and 4S neuroblastoma.
Cao L, Liu Q, Ma Y, Wang S
Clin Transl Oncol. 2023; 26(4):905-916.
PMID: 37709978
DOI: 10.1007/s12094-023-03320-4.
SMAD Proteins in TGF-β Signalling Pathway in Cancer: Regulatory Mechanisms and Clinical Applications.
Wang Q, Xiong F, Wu G, Wang D, Liu W, Chen J
Diagnostics (Basel). 2023; 13(17).
PMID: 37685308
PMC: 10487229.
DOI: 10.3390/diagnostics13172769.
Curcumin potentiates the anti-inflammatory effects of Tehranolide by modulating the STAT3/NF-κB signaling pathway in breast and ovarian cancer cell lines.
Afshari H, Noori S, Zarghi A
Inflammopharmacology. 2023; 31(5):2541-2555.
PMID: 37452228
DOI: 10.1007/s10787-023-01281-2.
Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.
Yarmolinsky J, Robinson J, Mariosa D, Karhunen V, Huang J, Dimou N
medRxiv. 2023; .
PMID: 37205426
PMC: 10187459.
DOI: 10.1101/2023.05.04.23289196.